Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Red Rock Resorts A | RRR | Apr 25, 2024 | 59.23 | -1.04 |
Red Violet | RDVT | Apr 25, 2024 | 16.98 | -0.18 |
RDDT | Apr 25, 2024 | 42.45 | 0.00 | |
Redfin | RDFN | Apr 25, 2024 | 5.18 | -2.81 |
RedHill Biopharma ADR | RDHL | Apr 25, 2024 | 0.42 | -0.87 |
Redwire | RDW | Apr 25, 2024 | 3.85 | +0.52 |
Redwood Trust | RWT-A | Apr 25, 2024 | 24.49 | -0.29 |
Redwood Trust | RWT | Apr 25, 2024 | 5.67 | -1.56 |
Redwoods Acquisition | RWOD | Apr 25, 2024 | 6.07 | -3.80 |
Regal Rexnord | RRX | Apr 25, 2024 | 161.97 | -1.38 |
Regency Centers | REG | Apr 25, 2024 | 59.06 | -0.92 |
Regency Centers A Pref | REGCP | Apr 25, 2024 | 22.82 | -0.95 |
Regency Centers B Pref | REGCO | Apr 25, 2024 | 22.52 | +0.31 |
Regeneron Pharmaceuticals | REGN | Apr 25, 2024 | 890.68 | -1.75 |
REGENXBIO | RGNX | Apr 25, 2024 | 16.06 | +0.12 |
Regional Health Properties | RHE | Apr 25, 2024 | 3.00 | +2.04 |
Regional Health Properties A Pref | RHE-A | Apr 25, 2024 | 0.85 | 0.00 |
Regional Management | RM | Apr 25, 2024 | 26.26 | -0.45 |
Regions Financial | RF | Apr 25, 2024 | 19.61 | -0.81 |
Regions Financial B Pref | RF-B | Apr 25, 2024 | 24.83 | -0.39 |
Regions Financial C Pref | RF-C | Apr 25, 2024 | 21.81 | -1.58 |
Regions Financial E Pref | RF-E | Apr 25, 2024 | 17.55 | -1.13 |
Regis | RGS | Apr 25, 2024 | 5.56 | +0.18 |
Regulus Therapeutics | RGLS | Apr 25, 2024 | 2.27 | +2.25 |
Reinsurance Group of America | RGA | Apr 25, 2024 | 191.06 | +0.03 |
REIT Index ETF Vanguard | VNQ | Apr 25, 2024 | 80.12 | -0.57 |
Rekor Systems | REKR | Apr 25, 2024 | 1.75 | -2.78 |
Relay Therapeutics | RLAY | Apr 25, 2024 | 6.16 | -3.07 |
Reliance | RS | Apr 25, 2024 | 292.13 | -6.83 |
Reliance Global | RELI | Apr 25, 2024 | 0.28 | -6.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.